← SynDRA
VANOXERINE
SynDRA canonical compound SYN0001195 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | SLC6A3 |
| Mechanism of action | Dopamine uptake inhibitor |
All known targets
Mechanisms of action (all sources)
- Dopamine uptake inhibitor
- SLC6A3 INHIBITOR
- dopamine reuptake inhibitor
- SLC6A3 BLOCKER
Drug classes
- Dopamine Uptake Inhibitors
Cross-references
Synonyms
- Vanoxerina
- GBR-12909
- Vanoxerinum
- Vanoxerine [INN]
- D-052
- Vanoxerina [INN-Spanish]
- Vanoxerinum [INN-Latin]
- Piperazine, 1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)-, dihydrochloride
- 1-(2 (Bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine di-hcl
- 1-(2-(Bis(p-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine
- 1-(2-bis-[4-FLUOROPHENYL]-METHOXYETHYL)-4-(3-PHENYL-2-PROPYL)PIPERAZINE
- 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine
- GBR12909
- Vanoxeamine
- CHEMBL281594
- CHEBI:64089
- 90X28IKH43
- 67469-69-9 (free base)
- GBR 12909;I893
- 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine
- Piperazine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)-
- CAS-67469-78-7
- UNII-90X28IKH43
- Tocris-0421
- SpecPlus_000900
- Lopac-D-052
- Prestwick0_000386
- Prestwick1_000386
- Prestwick2_000386
- Prestwick3_000386
- Biomol-NT_000010
- Lopac0_000446
- BSPBio_000571
- DivK1c_006996
- SCHEMBL246574
- SPBio_002492
- BPBio1_000629
- BPBio1_001141
Look up VANOXERINE in the interactive SynDRA portal →